Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1536398-19-2 | MDL No. : | MFCD28041153 |
Formula : | C11H16BN3O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KBNOLNOVDAQIAK-UHFFFAOYSA-N |
M.W : | 265.07 g/mol | Pubchem ID : | 75201243 |
Synonyms : |
|
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.55 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 6.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 72.21 |
TPSA : | 95.78 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.98 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | -0.09 |
Log Po/w (WLOGP) : | -1.83 |
Log Po/w (MLOGP) : | -0.91 |
Log Po/w (SILICOS-IT) : | -1.66 |
Consensus Log Po/w : | -0.9 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.4 |
Solubility : | 10.6 mg/ml ; 0.0401 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.47 |
Solubility : | 9.0 mg/ml ; 0.0339 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.12 |
Solubility : | 20.3 mg/ml ; 0.0766 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.69 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
[ 1411643-59-8 ]
(2-(Azetidin-1-yl)pyrimidin-5-yl)boronic acid
Similarity: 0.77
[ 870521-33-8 ]
2-Morpholinopyrimidin-5-ylboronic acid
Similarity: 0.75
[ 756817-82-0 ]
(2-(Dimethylamino)pyrimidin-5-yl)boronic acid
Similarity: 0.69
[ 957198-30-0 ]
4-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)morpholine
Similarity: 0.68
[ 1218791-44-6 ]
N-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine
Similarity: 0.66
[ 111247-60-0 ]
Ethyl 1-pyrimidin-2-yl-piperidine-4-carboxylate
Similarity: 0.76
[ 914347-01-6 ]
Methyl 1-(5-bromopyrimidin-2-yl)piperidine-4-carboxylate
Similarity: 0.70
[ 875318-46-0 ]
Ethyl 2-(4-(hydroxymethyl)piperidin-1-yl)pyrimidine-5-carboxylate
Similarity: 0.68
[ 1316216-05-3 ]
Ethyl 2-(diphenylamino)pyrimidine-5-carboxylate
Similarity: 0.53
[ 64951-07-1 ]
Ethyl imidazo[1,2-a]pyrimidine-3-carboxylate
Similarity: 0.50
[ 111247-60-0 ]
Ethyl 1-pyrimidin-2-yl-piperidine-4-carboxylate
Similarity: 0.76
[ 914347-01-6 ]
Methyl 1-(5-bromopyrimidin-2-yl)piperidine-4-carboxylate
Similarity: 0.70
[ 875318-46-0 ]
Ethyl 2-(4-(hydroxymethyl)piperidin-1-yl)pyrimidine-5-carboxylate
Similarity: 0.68
[ 799283-92-4 ]
1-(5-Bromopyrimidin-2-yl)piperidine-4-carboxylic acid
Similarity: 0.65
[ 893755-98-1 ]
1-(Pyrimidin-2-yl)piperidin-4-ol
Similarity: 0.58
[ 1411643-59-8 ]
(2-(Azetidin-1-yl)pyrimidin-5-yl)boronic acid
Similarity: 0.77
[ 111247-60-0 ]
Ethyl 1-pyrimidin-2-yl-piperidine-4-carboxylate
Similarity: 0.76
[ 870521-33-8 ]
2-Morpholinopyrimidin-5-ylboronic acid
Similarity: 0.75
[ 914347-01-6 ]
Methyl 1-(5-bromopyrimidin-2-yl)piperidine-4-carboxylate
Similarity: 0.70
[ 756817-82-0 ]
(2-(Dimethylamino)pyrimidin-5-yl)boronic acid
Similarity: 0.69